NasdaqGM - Delayed Quote • USD
Alimera Sciences, Inc. (ALIM)
At close: 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.06 | -0.01 | -0.01 | 0.2 |
| Low Estimate | -0.07 | -0.02 | -0.04 | 0.1 |
| High Estimate | -0.04 | 0 | 0.03 | 0.31 |
| Year Ago EPS | -0.71 | -1.32 | -0.79 | -0.01 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 22.25M | 25.18M | 103.79M | 118.79M |
| Low Estimate | 21M | 24.46M | 100M | 112.24M |
| High Estimate | 23.72M | 25.76M | 105.88M | 127.02M |
| Year Ago Sales | 13.55M | 17.54M | 80.75M | 103.79M |
| Sales Growth (year/est) | 64.30% | 43.60% | 28.50% | 14.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.32 | 0.01 | -0.06 | 0 |
| EPS Actual | -0.71 | -1.32 | -0.06 | -0.07 |
| Difference | -0.39 | -1.33 | 0 | -0.07 |
| Surprise % | -121.90% | -13,300.00% | 0.00% | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.01 | -0.01 | 0.2 |
| 7 Days Ago | -0.07 | -0.03 | -0.05 | 0.13 |
| 30 Days Ago | -0.07 | -0.03 | -0.07 | -0.05 |
| 60 Days Ago | -0.02 | 0 | 0.07 | 0.14 |
| 90 Days Ago | -0.02 | 0 | 0.07 | 0.14 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ALIM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 91.50% | -- | -- | 1.50% |
| Next Qtr. | 99.20% | -- | -- | 11.40% |
| Current Year | 98.70% | -- | -- | 5.20% |
| Next Year | 2,100.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 3/25/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Upgrade | Alliance Global Partners: Neutral to Buy | 6/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/25/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/19/2023 |
Related Tickers
ACUR Acura Pharmaceuticals, Inc.
0.0100
0.00%
EVOK Evoke Pharma, Inc.
0.4475
+0.90%
DERM Journey Medical Corporation
3.4000
-3.95%
39L.DU PetIQ Inc
15.40
0.00%
GRNF GRN Holding Corporation
0.0710
0.00%
SBBCF Simply Better Brands Corp.
0.2668
+4.18%
HCANF Halo Collective Inc.
0.0000
0.00%
CLVRW Clever Leaves Holdings Inc.
0.0400
0.00%
FITX Creative Edge Nutrition, Inc.
0.0000
0.00%
BFRIW Biofrontera Inc.
0.0550
+10.22%